Join the revolution: next-generation SPE
Thermo Scientific SOLA products revolutionize Solid Phase Extraction (SPE). This first fritless SPE product range provides greater reproducibility with cleaner, more consistent extracts.
Thermo Scientific SOLA SPE Cartridges and Plates
Thermo Scientific SOLA products revolutionize Solid Phase Extraction (SPE). This first fritless SPE product range provides greater reproducibility with cleaner, more consistent extracts. SOLA products provide unparalleled performance characteristics compared to conventional SPE, phospholipid removal and protein precipitation products.
This includes:
- Higher levels of reproducibility
- Higher levels of extract cleanliness
- Reduced solvent requirements
- Increased sensitivity
The proprietary manufacturing process involved in the production of SOLATM products provides an SPE product which eliminates issues normally associated with conventional loose-packed SPE products, by combining the polyethylene frit material and media components into a uniform sorbent bed, removing the need for frits.
In today’s high throughput laboratory environment where reproducibility, certainty of results and cost saving is a fundamental requirement, SOLA products are an indispensible tool to provide confidence and first time/every time success in the analytical process.
Learn more at: ref="http://www.thermoscientific.com/sola-spe">www.thermoscientific.com/sola-spe
Free Poster: NDSRI Risk Assessment and Trace-Level Analysis of N-Nitrosamines
April 25th 2025With increasing concern over genotoxic nitrosamine contaminants, regulatory bodies like the FDA and EMA have introduced strict guidelines following several high-profile drug recalls. This poster showcases a case study where LGC and Waters developed a UPLC/MS/MS method for quantifying trace levels of N-nitroso-sertraline in sertraline using Waters mass spectrometry and LGC reference standards.
New Guide: Characterising Impurity Standards – What Defines “Good Enough?”
April 25th 2025Impurity reference standards (IRSs) are essential for accurately identifying and quantifying impurities in pharmaceutical development and manufacturing. Yet, with limited regulatory guidance on how much characterisation is truly required for different applications, selecting the right standard can be challenging. To help, LGC has developed a new interactive multimedia guide, packed with expert insights to support your decision-making and give you greater confidence when choosing the right IRS for your specific needs.
Using the Carcinogenic Potency Categorisation Approach (CPCA) to Classify N-nitrosamine Impurities
April 25th 2025Learn how to manage nitrosamine impurities in pharmaceuticals with our free infographic. Discover how the CPCA approach establishes acceptable intake limits and guides the selection of NDSRI reference samples. Stay compliant and ensure safety with our ISO-accredited standards.
